Attached files
| file | filename |
|---|---|
| EX-99.1 - China Shenghuo Pharmaceutical Holdings Inc | v215683_ex99-1.htm |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 22, 2011
CHINA SHENGHUO PHARMACEUTICAL HOLDINGS, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
|
001-33537
|
20-2903562
|
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
No. 2, Jing You Road
|
|
|
Kunming National Economy &
|
|
|
Technology Developing District
|
|
|
People’s Republic of China 650217
|
N/A
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
0086-871-728-2628
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
On March 22, 2011, China Shenghuo Pharmaceutical Holdings, Inc. (the “Company”) issued a press release announcing the final approval by the court of a settlement agreement resolving and dismissing all claims asserted against the company in the consolidated class action lawsuit, Varghese, et al. v. China Shenghuo Pharmaceutical Holdings, Inc., et al.
A copy of the Company’s press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and the information therein is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
|
(d)
|
Exhibits
|
|
Exhibit
Number
|
Description
|
|
|
99.1
|
Press Release of China Shenghuo Pharmaceutical Holdings, Inc., dated March 22, 2011.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CHINA SHENGHUO PHARMACEUTICAL HOLDINGS, INC.
|
|||
|
Date: March 22, 2011
|
|||
|
By:
|
/s/ Gui Hua Lan
|
||
|
Name: Gui Hua Lan
Title: Chief Executive Officer
|
|||
EXHIBIT INDEX
|
Exhibit
Number
|
Description
|
|
|
99.1
|
Press Release of China Shenghuo Pharmaceutical Holdings, Inc., dated March 22, 2011.
|